Autologous Cell Therapy Market By Therapy (Allogenic Therapies, & Autologous Therapies), By Source (Bone Marrow & Epidermis), By Application (Neurology, Orthopedic, & Cancer), By End-User (Hospitals & Ambulatory Centers), And Region For 2024-2031
Report ID: 39196|No. of Pages: 202
Autologous Cell Therapy Market By Therapy (Allogenic Therapies, & Autologous Therapies), By Source (Bone Marrow & Epidermis), By Application (Neurology, Orthopedic, & Cancer), By End-User (Hospitals & Ambulatory Centers), And Region For 2024-2031
Autologous Cell Therapy Market Valuation – 2024-2031
The autologous cell therapy market size was valued at USD 11.97 Billion in 2023 and is projected to grow by 39.38 Billion by 2031, exhibiting a CAGR of 17.70% during the forecast period. The demand for autologous cell therapy is increasing due to its personalized treatment strategy which involves using a patient’s cells to treat problems such as cancer, cardiovascular disease, and neurological disorders. This therapy reduces the likelihood of immunological rejection and improves results contributing to its popularity.
Furthermore, advances in regenerative medicine, increased clinical trials, and greater awareness of the benefits of cell-based therapies all contribute to the market’s growth. As healthcare systems invest more in new treatments, the demand for autologous cell therapy will increase.
>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=39196
Global Autologous Cell Therapy Market: Definition/ Overview
Autologous cell therapy is a medical procedure employing the patient’s cells to repair or replace damaged tissues and treat disorders. The cells are collected, treated, and then returned to the patient’s body. This personalized technique decreases the danger of immunological rejection because the cells come from the same person. Autologous cell therapy is used to treat cancer, cardiovascular disease, and regenerative medicine, and it has shown encouraging outcomes in stem cell therapy and immune-based treatments.
It is primarily used to treat a wide range of illnesses by promoting repair and regeneration with a patient’s cells. It is widely used in regenerative medicine, particularly to treat cancer, autoimmune illnesses, cardiovascular problems, and neurological disorders. The therapy improves tissue repair, lowers inflammation, and aids in the regeneration of injured cells, lowering the likelihood of immunological rejection. Its personalized approach provides tailored medicines that improve patient outcomes and overall efficacy in treating complex diseases.
The future of autologous cell therapy seems bright with possible applications including regenerative medicine, personalized cancer treatments, and autoimmune illnesses. It is predicted to have an important role in treating disorders such as diabetes, Parkinson’s, and cardiovascular disease by rebuilding damaged tissues. Ongoing research seeks to improve its effectiveness, lower prices, and expedite manufacturing procedures.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
What's inside a VMR
industry report?
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=39196
How Does Rising Global Healthcare Spending Contribute to the Growth of the Autologous Cell Therapy Market?
Rising around the globe healthcare spending helps to drive the growth of the autologous cell therapy market by allowing for higher investment in modern medical technologies and innovative therapies. As healthcare budgets grow, more money is being committed to cell-based therapy research, development, and clinical trials, including autologous cell therapies. This enhanced financial support hastens the commercialization of these medicines, resulting in their adoption in hospitals and specialized clinics. Furthermore, increased healthcare spending enhances patient access to personalized, cutting-edge treatments which promotes market growth.
Furthermore, higher funding enables healthcare systems to invest in infrastructure such as specialized labs and equipment needed for the complex manufacturing procedures of autologous cell therapies. It also funds training for healthcare professionals in sophisticated therapeutic procedures which increases the availability and quality of these treatments. As global healthcare spending rises, the autologous cell therapy industry is poised for significant expansion fuelled by improved resources and increased patient access.
How Does the Manufacturing Complexity Serve as a Restraint in Scaling up Production in the Autologous Cell Therapy Market?
The manufacturing complexity of autologous cell therapy serves as a significant restraint in scaling up production due to its highly individualized nature. Each treatment requires cells to be extracted from the patient, processed in a specialized lab, and then reintroduced. This patient-specific approach limits the ability to mass-produce therapies as opposed to off-the-shelf treatments. The intricate processes demand state-of-the-art facilities, highly trained staff, and strict quality control measures all of which increase operational costs and slow down production capacity.
Furthermore, compliance with tight regulatory standards adds to the obstacles of scaling up. Because of the complexities of preserving sterility, sustaining cell viability, and sticking to exact timeframes, even tiny deviations can have an impact on treatment outcomes. These barriers make it difficult for manufacturers to streamline and optimize the manufacturing process limiting the overall growth and expansion of the autologous cell treatment market.
Category-Wise Acumens
How do Hospitals’ Access to Multidisciplinary Teams Contribute to the Success of Autologous Cell Therapy?
Hospitals dominate the autologous cell therapy industry due to their advanced infrastructure and availability of specialized equipment required for these complex treatments. Autologous cell treatment entails extracting, processing, and reinfusing a patient’s cells which necessitates sophisticated laboratories and stringent regulatory compliance. Hospitals, particularly those in major cities and specialized research facilities are well-equipped to handle these complex operations making them essential participants in this industry.
Furthermore, hospitals frequently have access to interdisciplinary teams including oncologists, immunologists, and regenerative medicine specialists which are required for the successful administration of autologous cell therapy. These institutions also benefit from established networks for patient referrals and clinical trials which gives them a competitive advantage in implementing and growing these novel treatments. With increasing investments in new therapies, hospitals are likely to maintain their dominant position providing the clinical environment for personalized, cell-based treatments to thrive.
How has the Rising Global Prevalence of Cancer Influenced the Demand for Autologous Cell Therapies in Oncology?
Oncology dominates the autologous cell therapy market due to the rising need for personalized cancer treatments. Autologous cell therapy, particularly CAR-T cell therapy, employs a patient’s immune cells to target and destroy cancer cells providing a more effective and personalized approach than previous therapies. This lowers the danger of immunological rejection and improves the chances of success in treating aggressive malignancies like leukemia and lymphoma. The rising global prevalence of cancer has increased the need for novel treatments establishing oncology as a prominent market driver.
Furthermore, substantial research and development activities as well as an increasing number of clinical trials for cancer medicines have hastened progress in autologous cell therapy. Regulatory approvals and investments in oncology-specific medicines such as CAR-T therapies are helping to boost this market. As a result, cancer continues to dominate the autologous cell treatment business generating significant interest from healthcare providers and investors.
Gain Access to Autologous Cell Therapy Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=39196
Country/Region-wise Acumens
How does the Regulatory Environment Facilitate the Clinical Trials and the Approval Process for New Autologous Cell Therapies in the North American Region?
North America dominates the autologous cell therapy market due to its advanced healthcare infrastructure, large expenditure in R&D, and the presence of prominent biotechnology businesses. The region has a strong foundation in regenerative medicine as well as a rigorous regulatory environment that facilitates clinical trials and the commercialization of novel therapeutics. Government initiatives as well as financing for stem cell research and cell-based therapeutics are driving the expansion of this market in North America.
Furthermore, the increased frequency of chronic diseases such as cancer, cardiovascular disease, and autoimmune disorders creates a great need for advanced treatments such as autologous cell therapy. The region’s supremacy is fuelled by a growing knowledge of personalized treatment and the availability of specialized healthcare services. The United States leads the industry with cutting-edge research institutes and collaborations between academic centers and biotech corporations assuring a steady stream of medicinal advances in this field.
How do Lower Operational Costs Impact the Establishment of Manufacturing and Research Centers for Autologous Cell Therapy in the Asia-Pacific Region?
Asia Pacific is the fastest-growing region in the autologous cell therapy market owing to increased investment in healthcare infrastructure, research, and clinical trials. Countries such as China, Japan, and South Korea are substantially investing in biotechnology and regenerative medicine which is driving research and development of cell therapies. Furthermore, increased rates of chronic diseases such as cancer and cardiovascular disease in the region drive the need for advanced treatment alternatives such as autologous cell therapy.
Furthermore, expanding government backing combined with favorable regulatory frameworks and increased knowledge of personalized medicine is driving up the uptake of these therapies. Asia Pacific also benefits from a big patient pool and lower operational costs which entice multinational corporations to set up manufacturing and research centers. These factors contribute to the region’s rapid expansion in the autologous cell therapy market cementing its position as a major participant in the global healthcare industry.
Competitive Landscape
The Autologous Cell Therapy Market is a dynamic and competitive space characterized by diverse players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations focus on innovating their product line to serve the vast population in diverse regions.
Some of the prominent players operating in the autologous cell therapy market include:
Lonza, Bristol Myers Squibb, Novartis, Autolus therapeutics, Pharmicell Co., Vericel Corporation, Castle Creek Biosciences, Lineage Cell Therapeutics Inc., BrainStorm Cell Therapeutics, Regeneus Ltd., Caladrius Biosciences, Opexa Therapeutics Inc., S. Stem Cell, Inc.,, Takeda Pharmaceutical Company Limited
Autologous Cell Therapy Market Recent Developments
- In March 2022, Novartis signed a first deal with Carisma Therapeutics to manufacture HER 2 targeted CAR-M cell treatment. This strategy enabled the company to provide CAR-M cell therapy to patients by using its advanced cell and gene production capabilities, resulting in revenue growth.
- In May 2020, Lonza and Noga Therapeutics cooperated to develop autologous lentiviral gene therapy on the Cocoon platform. This agreement enabled the company to introduce new autologous gene therapy for Primary Immune Deficiencies (PIDs) to clinics and patients. This technique assisted the corporation in strengthening commercial relationships and expanding its customer base.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2018-2031 |
| Growth Rate | CAGR 17.70% from 2024 to 2031 |
| Base Year for Valuation | 2023 |
| Historical Period | 2018-2022 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players |
|
| Customization | Report customization along with purchase available upon request |
Autologous Cell Therapy Market, By Category
Therapy:
- Allogenic Therapies
- Autologous Therapies
Source:
- Bone Marrow
- Epidermis
Application:
- Neurology
- Orthopedics
- Cancer
- Wound Healing (including Skin)
- Cardiovascular Disorders
- Autoimmune Disorders
End-User:
- Hospitals
- Ambulatory Centers
- Research Centers
Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL AUTOLOGOUS CELL THERAPY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL AUTOLOGOUS CELL THERAPY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL AUTOLOGOUS CELL THERAPY MARKET, BY SOURCE
5.1 Overview
5.2 Bone Marrow
5.3 Epidermis
6 GLOBAL AUTOLOGOUS CELL THERAPY MARKET, BY APPLICATION
6.1 Overview
6.2 Neurology
6.3 Orthopedic
6.4 Cancer
6.5 Wound Healing (including Skin)
6.6 Cardiovascular Disorders
6.7 Autoimmune Disorders
7 GLOBAL AUTOLOGOUS CELL THERAPY MARKET, BY END-USER
7.1 Overview
7.2 Hospitals
7.3 Ambulatory Centers
7.4 Research Centers
8 GLOBAL AUTOLOGOUS CELL THERAPY MARKET, BY THERAPY
8.1 Overview
8.2 Allogenic Therapies
8.3 Autologous Therapies
9 GLOBAL AUTOLOGOUS CELL THERAPY MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.2 Middle East and Africa
10 GLOBAL AUTOLOGOUS CELL THERAPY MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies
11 COMPANY PROFILES
11.1 Pharmicell Co. Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Castle Creek Biosciences Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Vericel Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Lineage Cell Therapeutics Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 BrainStorm Cell Therapeutics
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Caladrius Biosciences Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Opexa Therapeutics Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Regeneus Ltd.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Takeda Pharmaceutical Company Limited.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 U.S. Stem Cell Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 KEY DEVELOPMENTS
12.1 Product Launches/Developments
12.2 Mergers and Acquisitions
12.3 Business Expansions
12.4 Partnerships and Collaborations
13 Appendix
13.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
